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DObjective: Robotically assisted totally endoscopic coronary artery bypass grafting (TECAB) is a viable option
for closed chest coronary surgery, but it requires learning curves and longer operative times. This study evaluated
the effect of extended operation times on the outcome of patients undergoing TECAB.
Methods: From 2001 to 2009, 325 patients underwent TECAB with the da Vinci telemanipulation system.
Correlations between operative times and preoperative, intraoperative, and early postoperative parameters
were investigated. Receiver operating characteristic analysis was used to define the threshold of the procedure
duration above which intensive care unit stay and ventilation time were prolonged. Demographic data,
intraoperative and postoperative parameters, and survival data were compared.
Results: Patients with prolonged operative times more often underwent multivessel revascularization (P<.001)
and beating-heart TECAB (P ¼.023). Other preoperative parameters were not associated with longer operative
times. Incidences of technical difficulties and conversions (P<.001) were higher among patients with longer
operative times. Prolonged intensive care unit stay, mechanical ventilation, hospital stay, and with requirement
of blood products were associated with longer operative times. Receiver operating characteristic analysis
showed operative times>445 minutes and>478 minutes to predict prolonged (>48 hours) intensive care unit
stay and mechanical ventilation, respectively. Patients with procedures>478 minutes had longer hospital stays
and higher perioperative morbidity and mortality. Kaplan-Meier analysis revealed decreased survival among
patients with operative times>478 minutes.
Conclusions: Multivessel revascularization and conversions lead to prolonged operative times in totally endo-
scopic coronary artery bypass grafting. Longer operative times significantly influence early postoperative and
midterm outcomes. (J Thorac Cardiovasc Surg 2012;143:639-47)ASupplemental material is available online.During the last decade, totally endoscopic coronary artery
bypass grafting (TECAB) has become a feasible treatment
option for an increasing number of patients.1-3 Robotic
technology is the only reproducible method to perform
TECAB, working exclusively through thoracic ports. As
the procedure and technology have matured, it is possible
to successfully complete increasingly complex operations.
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The Journal of Thoracic and Cacan reduce postoperative pain and accelerate return to a nor-
mal lifestyle without increases in perioperative mortality
and morbidity.
These days, not only single and double TECAB proce-
dures (with the left and right internal thoracic arteries
[ITAs]) but also triple bypass grafting, Y-grafts, and hybrid
procedures are feasible at dedicated centers. Nevertheless,
the TECAB procedure is rather complex. Therefore, dry
laboratory and wet laboratory training models have been
established to reduce the learning curves of surgeons being
trained in TECAB. Schachner and associates5 recently
showed that TECAB can be well taught with a stepwise
training program involving portions of the procedure per-
formed by trainees. With such an approach, independent
performance after training can be within adequate time
limits with seemingly acceptable results. Nevertheless, the
TECAB procedure is associated with increased operative
times relative to a sternotomy approach. Longer operative
times in TECAB are associated with longer crossclamp
times, longer cardiopulmonary bypass times, and longer
single-lung ventilation times.6 All these factors could sig-
nificantly affect postoperative morbidity and mortality
among patients undergoing TECAB. In this study, we inves-
tigated whether prolonged operative times have an impactrdiovascular Surgery c Volume 143, Number 3 639
Abbreviations and Acronyms
ITA ¼ internal thoracic artery
LAD ¼ left anterior descending
TECAB ¼ totally endoscopic coronary artery
bypass grafting
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Don the postoperative outcome of patients undergoing TE-
CAB. We tried to identify preoperative risk factors for
prolonged operative times and to define the threshold of op-
eration duration beyond which perioperative and midterm
outcome was affected.MATERIALS AND METHODS
From 2001 to 2009, a total of 325 patients underwent TECAB at 2 cen-
ters (University Clinic of Cardiac Surgery, Innsbruck Medical University,
Innsbruck, Austria; and Department of Surgery, Division of Cardiac
Surgery, University of Maryland Medical Center, Baltimore, Md). Demo-
graphic data are listed in Table 1.
All patients scheduled for a single-vessel or multivessel totally endo-
scopic approach on the beating or the arrested heart were included in the
study. We have previously described the operative technique.7 Beating-
heart procedures were performed when the anatomy of the target vessels
was suitable for a beating-heart approach, and severely calcified target ves-
sels were regarded as contraindication to a beating-heart procedure. In
cases of contraindications for the endoballoon (eg, severely calcified fem-
oral vessels), a beating-heart procedurewas performed as a secondary strat-
egy. During the initial period of our program, we performedmore on-pump
arrested-heart procedures for safety reasons.
For preoperative planning, every patient underwent computed tomogra-
phy of the ascending aorta. Carotid duplex scanning was also done in every
case.
A video of the procedure is available online at http://www.orlive.com/
umm/videos/tecab-totally-endoscopic-coronary-artery-bypass and on the
Web site of the Minimally Invasive Robotic Association (http://www.
miraweb.org/video.htm).
All patients gave informed consent for the procedure. Data were entered
into an institutional review board–approved database. Most of the cases
performed at the University of Maryland were performed in a hybrid
room. The cases performed at Innsbruck Medical University were done
in a regular cardiac operating room with the use of an advanced mobile
C-arm.
Statistics
The data of the patients were prospectively collected and retrospectively
analyzed with SPSS statistical software (PASW version 18.0 for Macin-
tosh; IBM Corporation, Somers, NY). Categoric variables are shown as
number and percentage and continuous variables as median and range.
Operative times were correlated with continuous variables by means of
the Spearman test. To define cutoff levels from which point on prolonged
operative times negatively influence intensive care unit stay and mechani-
cal ventilation time, we used receiver operating characteristic analysis. For
comparison of continuous variables with and without prolonged operative
times, we used the Mann-Whitney test; for comparison of categoric vari-
ables, we used the c2 test. To compare the operative times of different
procedures, we used analysis of variance.
For multivariate analysis of risk factors for prolonged operative times,
the significant predictors of univariate analysis were entered into a binary
logistic regression model. The P value, theWald coefficient, and the hazard640 The Journal of Thoracic and Cardiovascular Surgratio with the 95% confidence interval were determined. Survivals were
compared with Kaplan-Meier analysis and log-rank testing.
Definitions
Operative times were defined as times from skin incision to skin closure.
This included intraoperative angiography, which was performed as quality
control in 235 of 325 patients. Median procedure time for the angiography
was 22 minutes (range, 10–110 minutes). This times was included in the
overall operative time. Technical difficulties during the operation were de-
fined as technical challenges that led to either prolongation of procedure
time for more than 15 minutes or conversion to a larger incision. Conver-
sion was defined as a switch to a larger incision, including thoracotomy
or sternotomy, during or immediately after the TECAB procedure. Me-
chanical ventilation times and intensive care unit stay longer than 48 hours
were defined as prolonged.
RESULTS
Preoperative demographic factors such as body mass in-
dex, EuroSCORE, New York Heart Association functional
classification, serum creatinine, and ejection fraction did
not show any significant correlation with operative times
(Table 2). in contrast, operative time was significantly cor-
related with intraoperative factors such as cardiopulmonary
bypass time (r ¼ 0.708, P<.001) and aortic occlusion time
(r ¼ 0.657, P<.001). Postoperative mechanical ventilation
time (r ¼ 0.356, P < .001), intensive care unit stay
(r ¼ 0.197, P<.001), hospital stay (r ¼ 0.268, P<.001),
and transfused packed red blood cell units (r ¼0.395, P>
.001) showed significant correlation with the operative
time (Table 2, Figure 1). Analysis of the receiver operating
characteristic curves showed that operative times of at least
445 minutes were predictive of prolonged intensive care
unit stay (>48 hours).The operative time cutoff level was
478 minutes for prediction of prolonged mechanical venti-
lation time (>48 hours, Figure 2). According to these re-
sults, we divided the patients into 2 groups (operative
time 478 minutes, n ¼ 56, and operative time <478
min, n ¼ 269). When comparing the demographic profiles
of these groups, we could not find any parameter that was
significantly different (Table 1). Comparison of intraopera-
tive and early postoperative data revealed significantly more
beating-heart procedures (71% vs 14%, P¼ .023) andmul-
tivessel procedures (69% vs 17%, P<.001) in the group
with prolonged operative times. The use of bilateral ITA
grafts (53% vs 6%, P< .001) was also more frequent.
We found intraoperative technical difficulties (anastomotic
problems, 20% vs 6%, P<.001, left ITA injuries, 16% vs
4%, P ¼ .003, and epimyocardial lesions, 16% vs 6%,
P ¼ .047) and conversions to larger thoracic incisions
(41% vs 8%, P<.001) significantly more often when op-
erative times were prolonged. Eight of the 46 conversions
of the series were performed because of an unsatisfying re-
sult of the intraoperative angiographic evaluation of the
quality of the anastomosis. When comparing the different
TECAB procedures, we could confirm as expected that
the operative times of more complex procedures wereery c March 2012
TABLE 1. Demographic data
All patients
(n ¼ 325)
Operative time
478 min (n ¼ 56)
Operative time
<478 min (n ¼ 269) P value
Age (y, median and range) 62 (31–90) 62 (43–82) 59 (31–90) .2
Male (no.) 240 (74%) 41 (80%) 193 (73%) .649
Female (no.) 84 (26%) 10 (20%) 70 (27%) .649
EuroSCORE (median and range) 2 (0–8) 2 (0–8) 2 (0–8) .14
Body mass index (kg/m2, median and range) 27 (14–47) 28 (14–46) 27 (19–47) .88
History of smoking (no.) 96 (30%) 15 (30%) 81 (31%) .399
Diabetes mellitus (no.) 61 (19%) 14 (28%) 47 (18%) .534
Hypercholesterolemia (no.) 203 (63%) 33 (65%) 170 (64%) .61
Arterial hypertension (no.) 243 (75%) 40 (71%) 203 (77%) .233
Previous percutaneous coronary intervention (no.) 77 (24%) 17 (34%) 60 (23%) .362
History of myocardial infarction (no.) 88 (27%) 16 (31%) 69 (26%) .380
Preoperative unstable angina (no.) 118 (36%) 2 (4%) 24 (9%) .387
History of thoracic surgery (no.) 1 (0.3%) 0 1 (0.4%) .641
Preoperative ejection fraction (%, median and range) 60% (20%–88%) 60% (35%–77%) 60% (20%–88%) .4
Peripheral vascular disease (no.) 8 (2.5%) 1 (2%) 7 (3%) .727
Preoperative serum creatinine (md/dL, median and range) 0.98 (0.48–8.70) 0.98 (0.66–2.1) 0.97 (0.48–8.7) .34
History of transient ischemic attack (no.) 11 (3%) 3 (6%) 8 (3%) .398
History of stroke (no.) 3 (1%) 1 (2%) 2 (0.8%) .469
Systolic pulmonary arterial pressure>60 mm Hg (no.) 1 (0.3%) 0 1 (0.4%) .658
Chronic obstructive pulmonary disease (all comers, no.) 32 (10%) 8 (16%) 24 (9%) .261
Preoperative intra-aortic counterpulsation pump (no.) 5 (2%) 1 (2%) 4 (2%) .556
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Dsignificantly longer than those of simpler operations. There
were no triple-vessel bypasses in this series. Overall, there
were 81 double-vessel TECABs, and among those 38 cases
were left ITA to left anterior descending (LAD) with
diagonal branch as jump graft. The other 43 cases were
double-vessel bypasses with bilateral ITA grafts. In these
cases, 1 target vessel was the LAD and the other was either
an obtuse marginal branch of the circumflex artery or the
right coronary artery.
Arrested-heart single left ITA to LAD cases lasted only
295 minutes (range, 175–690 minutes), whereas beating-
heart single left ITA to LAD cases needed 347 minutes
(range, 195–630 minutes). Whereas performing left ITA
to LAD with diagonal branch as jump graft, the arrested-TABLE 2. Correlations with operative time
Operative time
r value P value
EuroSCORE 0.065 .248
Body mass index 0.001 .986
Creatinine 0.036 .541
Ejection fraction 0.07 .913
New York Heart Association
functional class
0.103 .154
Intensive care unit stay 0.197 <.001
Ventilation time 0.356 <.001
Hospital stay 0.268 <.001
Packed red blood cell
transfusion
0.395 <.001
The Journal of Thoracic and Caheart cases lasted 355 minutes (range, 248–710 minutes),
the same procedure performed on the beating heart lasted
465 minutes (range, 360–667 minutes). More complex mul-
tivessel cases with bilateral ITA use lasted 502 minutes
(range, 330–724 minutes) on the arrested heart and 504
minutes (range, 360–667 minutes) on the beating heart
(P<.001) The requirement of packed red blood cell units
(3 units; range, 0–21 units; vs 1 unit; range, 0–12 units;
P<.001) was significantly higher when operative times ex-
ceeded 478 minutes. Requirement of intra-aortic counter-
pulsation pumps was significantly more prevalent among
patients with prolonged operative times (8% vs 0.4%,
P<.001). Postoperative complications including pneumo-
nia (14% vs 1%, P<.001), renal failure requiring hemofil-
tration (6% vs 0%, P<.001), sepsis (2% vs 0%, P ¼ .03),
and in-hospital mortality (4% vs 0%, P ¼ .002), were sig-
nificantly more frequent in the group with prolonged oper-
ative times.
Multivariate analysis showed that more complex proce-
dures (bilateral ITA cases, P< .001; hazard ratio, 9.674;
95% confidence interval, 2.885–32.445; Wald, 13.512;
and conversions, P<.001; hazard ratio, 8.897; 95% confi-
dence interval, 3.146–25.160; Wald, 16.980) were indepen-
dent predictors for prolonged operative times (Table 3).
Survivals were 99%, 98%, and 98%, respectively, in the
group without prolonged operative times at 12, 24, and 36
months after the operation. In the group with prolonged op-
erative times, survivals were 92%, 92%, and 92%, respec-
tively, at 12, 24, and 36 months after surgery (P ¼ .02;rdiovascular Surgery c Volume 143, Number 3 641
FIGURE 1. Scatter plots of most significant correlations. Operative time significantly correlates with mechanical ventilation time, intensive care unit (ICU)
stay, hospital stay, and transfused packed red blood cell units.
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CABs died. In the group with operative times shorter than
478 minutes 1 patient died of prostate cancer 24 months
after the procedure. The other 2 deaths in that group were
cardiac related: 1 sudden cardiac death at 4 postoperative
months and 1 myocardial infarction 23 months after sur-
gery. In the group with prolonged operative times (longer
than 478 minutes), 2 in-hospital deaths occurred: 1 was of
intracerebral bleeding and the other was a sudden cardiac
death. In the long-term follow-up, another patient in this
group died of myocardial infarction.
We identified 2 major factors influencing the operative
time in patients undergoing TECAB, namely intraoperative
technical problems, especially when leading to conversions,
and more complex multivessel revascularizations. Our re-
sults indicate that intraoperative technical challenges, ob-
served in 37% of our patients, not only prolong operative
times but are significant determinants of postoperative642 The Journal of Thoracic and Cardiovascular Surgoutcome. We defined surgical problems as listed in Table 4:
ITA injury, 9 (6%); anastomotic problems, 29 (9%);
problems with remote access, 52 (16%); port problems,
30 (9%); and epimyocardial lesions, 26 (9%). We divided
the patients into 2 groups, those without any surgical prob-
lems (n ¼ 205, 63%) and those with surgical problems
(n ¼ 120, 37%). If 1 or more of the listed events occurred,
a patient was added to the group with surgical problems
(Table E1). We found that patients with surgical problems
had significantly longer operative time (418 minutes; range,
245–724 minutes; vs 293 minutes; range, 175–656 minutes;
P< .001), as well as longer cardiopulmonary bypass and
aortic crossclamp times. There was no significant difference
between those with and without surgical problems in the
number of multivessel TECABs (36, 29%, vs 45, 23%,
P ¼ .18) or in the number of bilateral ITA cases (19,
16%, vs 22, 12%, P ¼ .3), but there were significantly
more beating-heart cases in the group with surgicalery c March 2012
FIGURE 2. A, Receiver operating characteristic analysis for prolonged
intensive care unit (ICU) stay. Operative (OR) times of 445 minutes go
along with significantly longer times in the intensive care unit. B, Receiver
operating characteristic analysis for prolonged mechanical ventilation
time. After a cutoff level of 478 minutes, longer operative (OR) time signif-
icantly prolongs the postoperative mechanical ventilation time.
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46 conversions were in the group with surgical problems
(P<.001).
Regarding the outcome parameters, intensive care unit
stay (22 hours; range, 14–389 hours; vs 20 hours; range,
11–1048 hours; P ¼ .022) and mechanical ventilation
time (12 hours; range, 0–288 hours; vs 7 hours; range,
0–349 hours; P<.001) were significantly longer in patients
with surgical problems The rates of transient ischemic at-
tack, stroke, postoperative renal failure, sepsis, deep sternal
wound infection, pneumonia, perioperative myocardial in-
farction, and in-hospital mortality were not significantly dif-
ferent between the groups.When comparing the survivals ofThe Journal of Thoracic and Capatients with and without surgical problems, we did not see
significant differences in Kaplan-Meier survival analysis
(Figure E1). Survivals were 98%, 98%, and 97%, respec-
tively, in the group without surgical problems at 12, 24,
and 36months after the operation. In the group with surgical
problems, survivals were 97%, 97%, and 95%, respec-
tively, at 12, 24, and 36 months after surgery (P ¼ .659).
DISCUSSION
TECAB with the da Vinci surgical telemanipulation sys-
tem (Intuitive Surgical, Inc, Sunnyvale, Calif) has become
a feasible procedure for coronary revascularization at spe-
cialized centers. It was the first robotic endoscopic cardiac
procedure reported and remains among the most complex
robotic surgical operations. Nevertheless, TECAB has
been criticized especially because of prolonged operative
times relative to open procedures. In this study, we tried
to identify predictors of prolonged operative time and ana-
lyzed the influence of operative times on the outcome of 325
patients undergoing TECAB.
More complex procedures have been associated with lon-
ger operative times. Apart from that, cases with operative
problems, especially those ending up in conversions, have
also been associated with prolonged operative times. In an
early larger series of TECAB procedures, de Canniere and
coworkers8 described conversion rates of 28%. Even
though the conversion rate in our series was significantly
lower (14%), conversion still remained a factor influencing
not only operative times but finally also the outcome of pa-
tients undergoing TECAB. In our study, it became clear that
intraoperative technical challenges impact operative times.
Anastomotic problems, left ITA injuries, and epimyocardial
lesions were more frequently found in the group of patients
with prolonged operative times. It therefore seems to be
very important to make all efforts to avoid any surgical
problems, and so meticulous attention has to be paid to ev-
ery detail. This becomes even more obvious when looking
at the conversion rates. Whereas patients with operative
times shorter than 478 minutes had an acceptable conver-
sion rate of 8%, patients with operative times exceeding
478 minutes had a conversion rate of 4 out of 10 patients.
When comparing the results of patients with and without
surgical problems, we found that the occurrence of 1 or
more surgical problems significantly prolonged the opera-
tive time from approximately 5 hours in the group without
surgical problems to approximately 7 hours in the group
with surgical problems. Nevertheless, this time is still 1
hour below our defined cutoff level of 8 hours. This shows
that surgical problems alone prolong the operative time but
in most cases it is still possible to stay under the 8-hour
limit. When looking at the operative times of complex
multivessel revascularizations with bilateral ITA use, 502
minutes on the arrested heart and 504 minutes on the
beating heart, it becomes clear that especially multivesselrdiovascular Surgery c Volume 143, Number 3 643
TABLE 3. Multivariate analysis for risk factors of prolonged operative time in 325 patients undergoing totally endoscopic coronary artery bypass
grafting
Variable P value Wald coefficient Odds ratio 95% Confidence interval
Bilateral thoracic artery <.001 13.512 9.674 2.885–32.445
Multivessel totally endoscopic coronary artery bypass grafting .088 2.905 2.609 0.866–7.859
Conversion <.001 16.980 8.897 3.146–25.160
Left internal thoracic artery injury .335 0.652 1.874 0.522–6.721
Epimyocardial lesion .836 2.663 1.137 0.337–3.832
Anastomotic problems .103 2.663 2.742 0.816–9.209
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pose a high risk for extraordinarily long operative times
and worse postoperative outcomes. Surgical problems
have significant influence on mechanical ventilation time,
intensive care unit stay, and hospital stay; however, the rates
of postoperative complications were not higher among
patients with surgical technical challenges.
Especially during the early period of our TECAB pro-
gram, we tried to select only low-risk patients, but with
a stepwise approach we slowly addressed more complex le-
sions. Nevertheless, the risk profile of our patients is lower
than that of the average patient with coronary artery disease
amenable to cardiac surgery. This shows that the TECAB
approach is not only attractive for patients and for surgeons
performing TECAB but also for referring cardiologists. For
low-risk patients, this minimally invasive approach seemsFIGURE 3. Kaplan-Meier survival curves comparing patients with and
without prolonged operative (OR) times. Survivals were 99%, 98%, and
98%, respectively, in the group without prolonged operative times at 12,
24, and 36 months after the operation. In the group with prolonged opera-
tive times, survivals were 92%, 92%, and 92%, respectively, at 12, 24, and
36 months after surgery (P ¼ .02). Median follow-up was 20 months
(range, 0–96 months).
644 The Journal of Thoracic and Cardiovascular Surgto be a more attractive alternative than standard CABG.
At our 2 centers, we are currently performing about 20%
of our CABG procedures with the TECAB technology.
The median operative time of 322 minutes in the overall
cohort is longer than the median operative time in standard
CABG, although it stays within the limits. Nevertheless
procedure times longer than 8 hours should, according to
our current analysis, be avoided.
The fact that the operative time among our last 50 pa-
tients was the same as that among our first 50 patients
(Appendix E1, Table E2) shows that we were able to im-
prove intraoperative performance and to speed up the proce-
dure as the complexity of the procedures (multivessel,
beating heart) increased. This shows that it is advisable to
start TECAB surgery with simple single left ITA to LAD
cases and to address more complex patients only with grow-
ing expertise.
There is very little information in the scientific literature
about the influence of operative time on the outcomes of
patients undergoing conventional or minimally invasive
cardiac surgery. Although some studies have shown that
minimally invasive approaches can be performed with satis-
fying outcomes comparable to those of open procedures,9,10
at least some of them have shown that the minimally
invasive approach is associated with longer operative
times than the open approach. Liu and coworkers11 com-
pared the outcomes of patients undergoing conventional
aortic valve replacement with those of patients undergoing
aortic valve replacement with a limited superior sternotomy.
The results of these groups were similar, apart from longer
operative times in patients undergoing upper hemisternot-
omy.11 Until now, however, no cutoff levels have been found
or investigated. Our study shows that TECAB can be per-
formed with satisfying outcomes, especially when staying
within certain boundaries regarding the operative time.
The operative times of other minimally invasive CABG
strategies are significantly shorter than the operative times
of TECAB. For single left ITA to LAD, minimally invasive
direct coronary artery bypass approach times as low as 105
minutes have been reported.12 Minimally invasive direct
coronary artery bypass and multivessel small thoracotomy
are attractive approaches for minimally invasive CABG,
too, and several groups have report rather promising results
with relatively low conversion rates.13 Nevertheless,ery c March 2012
TABLE 4. Intraoperative and early postoperative data
All patients
(n ¼ 325)
Operative time
477.5 min (n ¼ 56)
Operative time
<477.5 min (n ¼ 269) P value
Operative time (min, median and range) 322 (175–724) 552 (480–724) 300 (175–475) <.001
Cardiopulmonary bypass time (min, median and range) 106 (0–444) 196 (0–428) 94 (0–444) <.001
Aortic occlusion time (min, median and range) 67 (0–239) 135 (25–231) 63 (0–239) <.001
Left internal thoracic artery takedown time (min, median and range) 37 (16–85) 40 (26–95) 36 (4–72) .08
Right internal thoracic artery takedown time (min, median and range) 35 (19–95) 40 (26–95) 32 (19–72) .03
Anastomotic time, left anterior descending (min, median and range) 27 (10–100) 29 (14–100) 26 (10–67) .09
Anastomotic time, diagonal branch (min, median and range) 22 (10–50) 25 (22–29) 21 (10–50) .16
Anastomotic time, marginal branch (min, median and range) 27 (17–70) 29 (17–70) 24 (17–45) .19
Anastomotic time, right coronary artery (min, median and range) 27 (19–36) 22 (19–36) 32 (31–32) .36
Beating-heart TECAB (no.) 54 (17%) 36 (71%) 38 (14%) .023
Multivessel TECAB (no.) 81 (25%) 35 (69%) 46 (17%) <.001
Bilateral thoracic artery use (no.) 43 (13%) 27 (53%) 17 (6%) <.001
Left internal thoracic artery injury (no.) 19 (6%) 8 (16%) 11 (4%) .003
Anastomotic problem (no.) 29 (9%) 10 (20%) 17 (6%) <.001
Problems with remote access perfusion (no.) 52 (16%) 10 (20%) 39 (15%) .108
Port problems (no.) 30 (9%) 7 (14%) 23 (9%) .349
Epimyocardial lesion* (no.) 26 (8%) 8 (16%) 17 (6%) .047
Hybrid revascularization (no.) 133 (41%) 19 (37%) 111 (42%) .443
Conversion to larger incision (no.) 46 (14%) 21 (41%) 20 (8%) <.001
Intra-aortic counterpulsation (no.) 5 (1.5%) 4 (8%) 1 (0.4%) <.001
Perioperative myocardial infarction (no.) 8 (2.5%) 2 (4%) 5 (2%) .126
Intensive care unit stay (h, median and range) 20 (11–1048) 62 (14–1048) 20 (11–304) <.001
Ventilation time (h, median and range) 8 (0–349) 17 (3–349) 8 (0–183) <.001
Hospital stay (d, median and range) 6 (2–54) 9 (5–54) 6 (2–35) <.001
Packed red blood cells (units, median and range) 1 (0–21) 3 (0–21) 1 (0–12) <.001
Fresh-frozen plasma (units, median and range) 0 (0–31) 0 (0–31) 0 (0–15) .003
Transient ischemic attack (no.) 1 (0.3%) 0 1 (0.4%) .644
Stroke (no.) 6 (2%) 2 (4%) 4 (2%) .308
Pneumonia (no.) 10 (3%) 7 (14%) 3 (1%) <.001
Postoperative renal failure requiring hemofiltration (no.) 3 (1%) 3 (6%) 0 (0%) <.001
Deep sternal wound infection (after conversion, no.) 1 (0.3%) 0 (0%) 1 (0.4%) .638
In-hospital mortality (no.) 2 (0.6%) 2 (4%) 0 (0%) .002
Sepsis (no.) 1 (0.3%) 1 (2%) 0 (0%) .03
TECAB, Totally endoscopic coronary artery bypass grafting. *Epimyocardial lesion was any injury to the epicardium and superficial myocardium that did not result in ventricular
rupture but did result in some bleeding and needed to be treated either by suturing or by application of fibrin glue.
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vessel small thoractomy also have their shortcomings,14
such as difficulties in preparation of the ITA, bad exposure
of the target vessels, and the necessity of multiple thora-
cotomies in case of more complex multivessel revascular-
izations. Subramanian and colleagues15 reported a 3.8%
in-hospital mortality and a 92% early postoperative graft
patency rate in a series of 199 minimally invasive direct
coronary artery bypass procedures.
Nobody will doubt that 8 hours and longer represents an
extraordinary long operative time for routine CABG cases,
but at least most of our procedures could be performed below
this limit. Despite the fact that operative times longer than 8
hours for CABG procedures should not be the goal and
should not be accepted without any criticism, our study
shows that with a certain safety network, careful patient se-
lection, and meticulous handling, the outcomes of theseThe Journal of Thoracic and Capatients can remain comparable to those undergoing open
CABG procedures with shorter operative times even when
such long operative times occur. Nevertheless, it has to be
a futuregoal to reduceoperative times and to identify patients
at high risk for such long operative times. Some of those
should probably be excluded from a TECAB procedure.
Overall, we can recommend that operative times of 8
hours and longer should be avoided. One should be rather
proactive toward a conversion when the 8-hour limit is
about to be exceeded. Nevertheless, we should not recom-
mend conversion for every patient with prolonged operative
time. Individual decisions are necessary. When operative
problems occur and the operative time is already about to
exceed the 8-hour limit, from our point of view an immedi-
ate conversion should be the consequence. If only the pa-
tient setup or the harvesting and preparation of the ITAs
lasts long, and the remainder of the procedure can mostrdiovascular Surgery c Volume 143, Number 3 645
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operative times can probably be tolerated.
Mihaljevic and associates16 recently reported on results
of robotic mitral valve repair in comparison with open ap-
proaches and minithoracotomy approaches. The robotic ap-
proach required an increased operative time but resulted in
a reduced hospital stay. The operative time in that series,
however, was in the 6-hour range, and complex mitral valve
repair was not included. In addition, a low-risk patient
cohort was treated.
The perioperative results in our whole series of robotic
TECAB and results in patients who were operated within
the 8-hour time limit were very acceptable. Perioperative
mortality was clearly lower than predicted by EuroSCORE.
Morbidity in patients with prolonged operative time primar-
ily included respiratory issues and a prolonged ventilation
time. Single-lung ventilation, which is a necessary measure
in TECAB, has probably contributed to respiratory prob-
lems; additionally, an increased number of blood transfu-
sions and prolonged cardiopulmonary bypass times may
have been causal factors. A higher incidence of renal failure
after prolonged surgery can be explained by extended times
on heart–lung machine support, by longer times of single-
lung ventilation and continuous thoracic carbon dioxide in-
flation, and by lower systemic perfusion pressures in cases
of significant surgical bleeding. Increased rates of pneumo-
nia and sepsis in patients with extensive operative times
may be due to a depressed state of the immune system
and a prolonged application of invasive measures in the
operating room and the intensive care unit.
There was a 6% lower survival at 3 years among patients
with significantly prolonged operative times, and most
deaths occurred during the first 6 postoperative months.
The fact that there was no significant difference in survival
between patients with and without surgical problems shows
that surgical problems alone, even though they are an im-
portant factor, are not the only causal factors of adverse
postoperative outcome for patients undergoing TECAB.
Other factors, such as the complexity of the procedure,
may also have a significant impact not only on operative
time but also on postoperative outcome.
Our results clearly show that the overall survival of
patients undergoing TECAB is within the range of conven-
tional CABG, and the 99% 1-year survival and 98% 3-year
survival among patients with operative times below the cut-
off value can both be regarded as exceptionally good. It has
to be pointed out that only 6 patients in the whole series of
325 TECAB procedures died perioperatively or during the
follow-up period. In the group with operative times shorter
than 478 minutes, there were no in-hospital deaths, and 1 of
the 3 patients who died in the long-term follow-up actually
died of prostate cancer. In the group with prolonged opera-
tive times, 1 of the 2 in-hospital deaths was due to intrace-
rebral bleeding. In the long-term follow-up, 1 other patient646 The Journal of Thoracic and Cardiovascular Surgin that group died of cardiac causes. This means that means
that only 4 of the 6 deaths in our series were cardiac related.
The possible beneficial effects of TECAB, such as
smaller incisions, preservation of the integrity of the chest
wall, better cosmesis, shorter hospital stay, and quality of
life improvement, overcome such disadvantages as longer
operative times and higher costs and resource use. Never-
theless, we are aware that TECAB remains an approach
for a selected group of patients and will probably be per-
formed only in dedicated centers.
Our results indicate that operative time is an issue and
that measures that can dampen learning curves and speed
up the operative time are mandatory. We conclude that mul-
tivessel revascularization, operations on the beating heart,
and technical difficulties can lead to prolonged operative
times in robotic TECAB. Operative times as long as 8 hours
seem to be tolerable and are associated with excellent peri-
operative and long-term outcomes, whereas procedures ex-
ceeding the 8-hour time frame may be associated with
increased perioperative morbidity and mortality, as well
as decreased long-term survival. Complex multivessel pro-
cedures should receive special surgical attention.References
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APPENDIX E1. RESULTS OF THE FIRST 50
PATIENTS TO UNDERGO TOTALLY ENDOSCOPIC
CORONARYARTERY BYPASS GRAFTING IN
COMPARISON TO THE LAST 50 PATIENTS
Another important issue regarding operative times and
operative problems is the development of the totally endo-
scopic coronary artery bypass grafting program and the
increasing expertise of the surgeons with the growing
case number. We analyzed the results and the characteris-
tics of the first and last 50 patients undergoing totally en-
doscopic coronary artery bypass grafting within our
program (Table E2). With time, we tackled more complex
lesions. There were significantly more multivessel revascu-
larizations (n¼ 6, 12%, vs n¼ 16, 31%), bilateral internal
thoracic artery use (n ¼ 2, 4%, vs n ¼ 11, 22%), and
beating-heart procedures (n ¼ 8, 16%, vs n ¼ 20, 39%)
among the last 50 patients than among the first 50. Both
operative time (365 minutes; range, 243–724 minutes; vs
335 minutes; range, 194–692 minutes) and aortic occlusion
time (77 minutes; range, 0–223 minutes; vs 71 minutes;
range, 0–147 minutes) were not significantly different,
whereas the cardiopulmonary bypass time was signifi-
cantly longer in the group of the first 50 patients (120 min-
utes; range, 0–368 minutes; vs 96 minutes; range, 0–348
minutes). There were 10 conversions among the first 50 pa-
tients (20%) and 5 (10%) among the last 50 patients
(P ¼ .14), and surgical problems occurred in 26 of the first
50 patients (52%) and in 16 of the last 50 patients (31%,
P ¼ .08). The were no differences in rates of transient is-
chemic attack, stroke, pneumonia, sepsis, deep sternal
wound infection, renal failure, postoperative myocardial
infarction, and in-hospital mortality (no in-hospital deaths
among the first 50 patients vs 2 in-hospital deaths [4%]
among the last 50 patients, P ¼ .247). Intensive care unit
stay, mechanical ventilation time, and hospital stay were
equivalent between the groups.
FIGURE E1. Kaplan-Meier survival curves comparing patients with and
without surgical problems (prob). Survivals were 98%, 98%, and 97%, re-
spectively, in the group without surgical problems at 12, 24, and 36 months
after the operation. In the group with surgical problems, survivals were
97%, 97%, and 95%, respectively, at 12, 24, and 36 months after surgery
(P ¼ .659). Median follow-up was 20 months (range, 0–96 months).
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TABLE E1. Clinical data of patients with and without surgical problems
Surgical problems
(n ¼ 120, 37%)
No surgical problems
(n ¼ 205, 63%) P value
Operative time (min, median and range) 418 (245–724) 293 (175–656) <.001
Cardiopulmonary bypass time (min, median and range) 139 (0–444) 92 (0–270) <.001
Crossclamp time (min, median and range) 86 (0–239) 63 (0–153) <.001
EuroSCORE (median and range) 2 (0–7) 1.5 (0–8) .181
Intensive care unit stay (h, median and range) 22 (14–389) 20 (11–1048) .022
Mechanical ventilation time (h, median and range) 12 (0–288) 7 (0–349) <.001
Hospital stay (d, median and range) 7 (2–23) 6 (3–54) .065
Packed red blood cells (units, median and range) 2 (0–21) 0 (0–8) <.001
Multivessel TECAB (no.) 36 (29%) 45 (23%) .18
Beating-heart TECAB (no.) 28 (22%) 26 (13%) .037
Bilateral internal thoracic artery use (no.) 19 (16%) 22 (12%) .3
Conversion (no.) 45 (36%) 1 (0.5%) <.001
Transient ischemic attack (no.) 1 (0.8%) 0 .39
Stroke (no.) 4 (3%) 4 (2%) .68
Renal failure requiring hemofiltration (no.) 2 (1.7%) 0 .15
Sepsis (no.) 1 (0.8%) 0 .39
Deep sternal wound healing problems (after conversion, no.) 1 (0.8%) 0 .39
In-hospital mortality (no.) 2 (2%) 2 (1%) .63
Perioperative myocardial infarction (no.) 5 (4.2%) 2 (1%) .12
Intra-aortic counterpulsation pump (no.) 3 (2.5%) 1 (0.5%) .3
Pneumonia (no.) 5 (4%) 5 (3%) .6
TECAB, Totally endoscopic coronary artery bypass grafting.
TABLE E2. Program development
First 50 Last 50 P value
Male (no.) 37 (74%) 39 (77%) .5
Age (y, median and range) 59 (42–74) 59 (42–77) .626
EuroSCORE (median and range) 1 (0–4) 2 (0–8) .008
Beating-heart TECAB 8 (16%) 20 (39%) .013
Multivessel TECAB 6 (12%) 16 (31%) .028
Bilateral internal thoracic artery use (no.) 2 (4%) 11 (22%) .015
Conversion (no.) 10 (20%) 5 (10%) .14
Surgical problems (no.) 26 (52%) 16 (31%) .08
Perioperative myocardial infarction (no.) 3 (6%) 0 .243
Intra-aortic counterpulsation pump (no.) 1 (2%) 0 .521
Transient ischemic attack (no.) 0 0 NA
Stroke (no.) 0 1 (2%) .222
Pneumonia (no.) 3 (6%) 1 (2%) .540
Sepsis (no.) 1 (2%) 0 .521
Deep sternal wound infection (no.) 0 1 (2%) .479
In-hospital mortality (no.) 0 2 (4%) .247
Operative time (min, median and range) 365 (243–724) 335 (194–692) .237
Cardiopulmonary bypass time (min, median and range) 120 (0–368) 96 (0–348) .033
Aortic crossclamp time (min, median and range) 77 (0–223) 71 (0–147) .471
Intensive care unit stay (h, median and range) 24 (11–389) 25 (13–384) .994
Hospital stay (d, median and range) 7 (2–22) 7 (3–35) .690
Packed red blood cells (units, median and range) 2 (0–21) 2 (0–7) .635
Renal failure requiring hemofiltration (no.) 0 0 NA
TECAB, Totally endoscopic coronary artery bypass grafting; NA, not applicable.
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